Year archive

ALIVUS LIFE SCIENCES LIMITED — 2026 filings

All 38 regulatory filings released by ALIVUS LIFE SCIENCES LIMITED (ALIVUS) in 2026, sourced directly from the official regulator.

38 Filings

2026 Period

2026 filings (38)

Filing	Released	Lang
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-05-21	English
Please find enclosed herewith transcript of Earnings Call held on 15th May, 2026, which is also made available on the website of the Company. Call Transcript	2026-05-21	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-05-20	English
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting Regulatory Filings	2026-05-20	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-05-19	English
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting Regulatory Filings	2026-05-19	English
Analysts/Institutional Investor Meet/Con. Call Updates Report Publication Announcement	2026-05-15	English
We hereby confirm that we have uploaded audio recording of the Q4 & FY2025-26 Earnings Call held on May 15, 2026 on the website of the Company. Report Publication Announcement	2026-05-15	English
Please find enclosed herewith Investors Presentation for Q4 & FY 2025-26 Investor Presentation	2026-05-14	English
Investor Presentation Investor Presentation	2026-05-14	English
Enclosed please find herewith Press Release of the Company for the fourth quarter and year ended March 31, 2026. Earnings Release FY 2026	2026-05-14	English
Press Release Earnings Release FY 2026	2026-05-14	English
ESOP/ESOS/ESPS Share Issue/Capital Change	2026-05-14	English
Enclosed please find herewith intimation with respect to allotment of Equity Shares under the "Employee Stock Option Scheme, 2021". Share Issue/Capital Change	2026-05-14	English
We wish to inform you that the Board of Directors at its meeting held today i.e., May 14, 2026, has inter-alia approved the Audited Financial Results for the quarter and year ended March .... Interim / Quarterly Report FY 2026	2026-05-14	English
Dividend Interim / Quarterly Report FY 2026	2026-05-14	English
Outcome of Board Meeting Interim / Quarterly Report FY 2026	2026-05-14	English
Enclosed please find herewith Audited financial results for the quarter and year ended March 31, 2026 Interim / Quarterly Report FY 2026	2026-05-14	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-05-08	English
Trading Window Regulatory Filings	2026-05-07	English
General Updates Regulatory Filings	2026-03-21	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-03-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-03-06	English
Updates Regulatory Filings	2026-02-25	English
General Updates Regulatory Filings	2026-02-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-02	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-01-30	English
General Updates Regulatory Filings	2026-01-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-01-28	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-01-22	English
Investor Presentation Investor Presentation	2026-01-22	English
Press Release Earnings Release	2026-01-22	English
Outcome of Board Meeting Regulatory Filings	2026-01-22	English
ESOP/ESOS/ESPS Regulatory Filings	2026-01-21	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-01-15	English
Board Meeting — Board Meeting Intimation Regulatory Filings	2026-01-14	English
Trading Window Regulatory Filings	2026-01-14	English
Board Meeting — Financial Results Regulatory Filings	2026-01-14	English